Zhou ZL - Search Results

1

PD-L1 blockade liberates intrinsic antitumourigenic properties of glycolytic macrophages in hepatocellular carcinoma.

Lu LG, Zhou ZL, Wang XY, Liu BY, Lu JY, Liu S, Zhang GB, Zhan MX, Chen Y. Lu LG, et al. Among authors: zhou zl. Gut. 2022 Dec;71(12):2551-2560. doi: 10.1136/gutjnl-2021-326350. Epub 2022 Feb 16. Gut. 2022. PMID: 35173040 Free PMC article.

2

TRIB3 rs6037475 is a potential biomarker for predicting felodipine drug response in Chinese patients with hypertension.

He F, Sun B, Li L, Liu M, Lin W, Liu L, Sun Y, Luo Y, Wu L, Lu L, Zhang W, Zhou Z. He F, et al. Ann Transl Med. 2020 Apr;8(7):437. doi: 10.21037/atm.2020.03.176. Ann Transl Med. 2020. PMID: 32395481 Free PMC article.

3

C118P, a novel microtubule inhibitor with anti-angiogenic and vascular disrupting activities, exerts anti-tumor effects against hepatocellular carcinoma.

Yang M, Su Y, Wang Z, Du D, Wei S, Liao Z, Zhang Q, Zhao L, Zhang X, Han L, Jiang J, Zhan M, Sun L, Yuan S, Zhou Z. Yang M, et al. Biochem Pharmacol. 2021 Aug;190:114641. doi: 10.1016/j.bcp.2021.114641. Epub 2021 May 30. Biochem Pharmacol. 2021. PMID: 34077738 Free article.

4

Genetic Diversity and Characteristics of bla _NDM-Positive Plasmids in Escherichia coli.

Zhang Z, Guo H, Li X, Li W, Yang G, Ni W, Zhan M, Lu L, Zhang Z, Li X, Zhou Z. Zhang Z, et al. Front Microbiol. 2021 Nov 16;12:729952. doi: 10.3389/fmicb.2021.729952. eCollection 2021. Front Microbiol. 2021. PMID: 34867846 Free PMC article.

5

Impaired function of dendritic cells within the tumor microenvironment.

Xiao Z, Wang R, Wang X, Yang H, Dong J, He X, Yang Y, Guo J, Cui J, Zhou Z. Xiao Z, et al. Front Immunol. 2023 Jun 27;14:1213629. doi: 10.3389/fimmu.2023.1213629. eCollection 2023. Front Immunol. 2023. PMID: 37441069 Free PMC article. Review.

6

AMPK: An energy sensor for non-small cell lung cancer progression and treatment.

Zhong ZT, Wang XY, Pan Y, Zhou K, Chen JH, Gao YQ, Dai B, Zhou ZL, Wang RQ. Zhong ZT, et al. Among authors: zhou zl. Pharmacol Res. 2025 Jan 11;212:107592. doi: 10.1016/j.phrs.2025.107592. Online ahead of print. Pharmacol Res. 2025. PMID: 39805353 Review.

7

Tribbles pseudokinase 3 (TRIB3) contributes to the progression of hepatocellular carcinoma by activating the mitogen-activated protein kinase pathway.

Wang RQ, He FZ, Meng Q, Lin WJ, Dong JM, Yang HK, Yang Y, Zhao M, Qiu WT, Xin YJ, Zhou ZL. Wang RQ, et al. Among authors: zhou zl. Ann Transl Med. 2021 Aug;9(15):1253. doi: 10.21037/atm-21-2820. Ann Transl Med. 2021. PMID: 34532390 Free PMC article.

8

Tumor immunotherapy resistance: Revealing the mechanism of PD-1 / PD-L1-mediated tumor immune escape.

Cui JW, Li Y, Yang Y, Yang HK, Dong JM, Xiao ZH, He X, Guo JH, Wang RQ, Dai B, Zhou ZL. Cui JW, et al. Among authors: zhou zl. Biomed Pharmacother. 2024 Feb;171:116203. doi: 10.1016/j.biopha.2024.116203. Epub 2024 Jan 26. Biomed Pharmacother. 2024. PMID: 38280330 Free article. Review.

9

Exploring the pharmacological mechanism of Wuzhuyu decoction on hepatocellular carcinoma using network pharmacology.

Ouyang JY, Lin WJ, Dong JM, Yang Y, Yang HK, Zhou ZL, Wang RQ. Ouyang JY, et al. Among authors: zhou zl. World J Clin Cases. 2023 Sep 26;11(27):6327-6343. doi: 10.12998/wjcc.v11.i27.6327. World J Clin Cases. 2023. PMID: 37900230 Free PMC article.

10

Single-Cell RNA Sequencing Analysis of the Heterogeneity in Gene Regulatory Networks in Colorectal Cancer.

Wang RQ, Zhao W, Yang HK, Dong JM, Lin WJ, He FZ, Cui M, Zhou ZL. Wang RQ, et al. Among authors: zhou zl. Front Cell Dev Biol. 2021 Nov 30;9:765578. doi: 10.3389/fcell.2021.765578. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34917613 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

327 results

Search Page

Filters